Hiroko Wakimoto
- Molecular Biology top 5%
- Cardiology and Cardiovascular Medicine top 0.5%
- Epidemiology top 10%
- Surgery top 10%
- Genetics top 10%
- Co-authors
- Christine E. SeidmanJonathan G. SeidmanJoshua GorhamCharles I. BerulColin T. MaguireJianming JiangJosef GehrmannPeter E. Hammer
- Topics
- Cardiomyopathy and Myosin Studies (26 papers)Cardiac electrophysiology and arrhythmias (19 papers)Congenital heart defects research (17 papers)
- Partner nations
- United StatesJapanIsrael
In The Last Decade
Hiroko Wakimoto
74 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Molecular Biology 2.5k
- Cardiology and Cardiovascular Medicine 2.2k
- Epidemiology 439
- Surgery 351
- Genetics 236
Countries citing papers authored by Hiroko Wakimoto
This map shows the geographic impact of Hiroko Wakimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Wakimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Wakimoto more than expected).
Fields of papers citing papers by Hiroko Wakimoto
This network shows the impact of papers produced by Hiroko Wakimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Wakimoto. The network helps show where Hiroko Wakimoto may publish in the future.
Co-authorship network of co-authors of Hiroko Wakimoto
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Wakimoto. A scholar is included among the top collaborators of Hiroko Wakimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Wakimoto. Hiroko Wakimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 13 | |
| 3 | Efficient in vivo genome editing prevents hypertrophic cardiomyopathy in micebreakdown → | 106 |
| 4 | 17 | |
| 5 | 10 | |
| 6 | 83 | |
| 7 | MYBPC3 Mutations Cause Hypertrophic Cardiomyopathy by Dysregulating Myosin: Implications for Therapy | 1 |
| 8 | A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in micebreakdown → | 467 |
| 9 | 73 | |
| 10 | 29 | |
| 11 | 20 | |
| 12 | 1 | |
| 13 | 353 | |
| 14 | Abstract 2277: Verapamil Prevents Fatal Arrhythmia by Blocking Cardiac Ryanodine Receptor in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia Carrying Calsequestrin-2 Mutation | 1 |
| 15 | 1 | |
| 16 | 129 | |
| 17 | 7 | |
| 18 | 39 | |
| 19 | 14 | |
| 20 | 106 |
About Hiroko Wakimoto
Hiroko Wakimoto is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics, having authored 76 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (26 papers), Cardiac electrophysiology and arrhythmias (19 papers) and Congenital heart defects research (17 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (2.2k citations), Molecular Biology (2.5k citations) and Aging (29 citations). Hiroko Wakimoto has collaborated with scholars based in United States, Japan and Israel. Frequent co-authors include Christine E. Seidman, Jonathan G. Seidman, Joshua Gorham, Charles I. Berul, Colin T. Maguire, Jianming Jiang, Josef Gehrmann, Peter E. Hammer, David A. Conner and Daniel M. DeLaughter. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.